Forest, AstraZeneca in ceftaroline deal

Forest Laboratories Inc. (NYSE:FRX) granted AstraZeneca plc (LSE:AZN; NYSE:AZN) exclusive rights to co-develop and to commercialize ceftaroline outside the U.S., Canada and Japan. Forest plans to subm...